通化金马：拟7000万元设立全资子公司桂林金马创新投资

Core Viewpoint - Tonghua Golden Horse announced the establishment of a wholly-owned subsidiary, Guilin Jinma Innovation Investment Co., Ltd., with an investment of 70 million yuan to enhance its strategic transformation in the innovative pharmaceutical industry [1] Group 1: Company Actions - The company will hold its 11th board meeting on November 6, 2025, to approve the investment proposal [1] - The investment will be funded through the company's own or raised funds, and the company will hold 100% of the new subsidiary [1] - The investment decision falls within the board's approval authority and does not constitute a related party transaction or a major asset restructuring [1] Group 2: Strategic Intent - The purpose of this investment is to conduct mergers and acquisitions in the innovative pharmaceutical sector as part of the company's transformation strategy [1] - The company acknowledges that the investment may be influenced by industry policies but believes it will help optimize its industrial layout [1]